Product Description: Niloticin, tetracyclic triterpenoid compound, is a osteoclastogenesis inhibitor. Niloticin shows anti-viral, antioxidative, and mosquitocidal activities. Niloticin inhibits osteoclastogenesis by blocking RANKL-RANK interaction and suppressing the AKT, MAPK, and NF-κB signaling pathways[1].
Applications: COVID-19-anti-virus
Formula: C30H48O3
References: [1]Xu H, et al. Niloticin inhibits osteoclastogenesis by blocking RANKL-RANK interaction and suppressing the AKT, MAPK, and NF-κB signaling pathways. Biomed Pharmacother. 2022 May;149:112902.
CAS Number: 115404-57-4
Molecular Weight: 456.70
Research Area: Infection
Solubility: 10 mM in DMSO
Target: Akt;NF-κB